MktsMarkets

Core Laboratories Inc.
NYSE: CLBKey statistics
CLB News
Stories mentioning CLB from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 121,797 | 138,255 | 134,521 | 130,159 | 123,585 | 129,237 | 134,397 | 130,577 |
| Cost of Goods Sold | 102,073 | 109,516 | 104,901 | 103,701 | 99,469 | 106,199 | 106,805 | 102,930 |
| Gross Profit | 19,724 | 28,739 | 29,620 | 26,458 | 24,116 | 23,038 | 27,592 | 27,647 |
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | ||||||||
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | 1,887 | 15,832 | 20,928 | 15,291 | 4,417 | 14,174 | 19,803 | 16,008 |
| Interest Income | ||||||||
| Interest Expense | 2,891 | 2,609 | 2,650 | 2,711 | 2,602 | 2,629 | 3,108 | 3,209 |
| Other Expense | 645.00 | 1,392 | 5,590 | 2,967 | (2,335) | 3,880 | 4,529 | 2,390 |
| Pretax Income | (1,004) | 13,223 | 18,278 | 12,580 | 1,815 | 11,545 | 16,695 | 12,799 |
| Tax Provision | (251.00) | 8,094 | 3,754 | 1,911 | 1,746 | 4,076 | 4,691 | 3,609 |
| Net Income (Loss) | (789.00) | 4,948 | 14,239 | 10,636 | (154.00) | 7,403 | 11,745 | 9,032 |
| Earnings Per Share (Basic) | (0.02) | 0.11 | 0.31 | 0.23 | 0.00 | 0.16 | 0.25 | 0.19 |
| Earnings Per Share (Diluted) | (0.02) | 0.11 | 0.30 | 0.22 | 0.00 | 0.16 | 0.25 | 0.19 |
| Weighted Average Shares Outstanding (Basic) | 46,073 | 46,427 | 46,263 | 46,632 | 46,773 | 46,897 | 46,922 | 46,908 |
| Weighted Average Shares Outstanding (Diluted) | 46,073 | 47,028 | 47,078 | 47,364 | 46,773 | 47,685 | 47,820 | 47,743 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About CLB
Core Laboratories Inc. (NYSE: CLB) is a stock listed on the New York Stock Exchange under the ticker symbol CLB. It last traded at $8.84 (Nov 6, 2026, 9:30 AM ET), down 1.0% on the day. That gives Core Laboratories a market capitalisation of $454.7M and a price-to-earnings ratio of 18.7.
Over the past 52 weeks CLB has traded between $8.75 and $20.36.
Revenue for the quarter ended Mar 31, 2026 was $121.8M; a net loss of $789.0K. Revenue was down 1.4% from $123.6M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $121.8M | -$789.0K | -0.6% |
| Dec 31, 2025 | $138.3M | $4.9M | 3.6% |
| Sep 30, 2025 | $134.5M | $14.2M | 10.6% |
| Jun 30, 2025 | $130.2M | $10.6M | 8.2% |
From Core Laboratories’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…